1. Home
  2. RDI vs NXPL Comparison

RDI vs NXPL Comparison

Compare RDI & NXPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RDI

Reading International Inc

HOLD

Current Price

$1.04

Market Cap

25.2M

ML Signal

HOLD

Logo NextPlat Corp

NXPL

NextPlat Corp

HOLD

Current Price

$0.60

Market Cap

25.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
RDI
NXPL
Founded
1937
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Movies/Entertainment
Telecommunications Equipment
Sector
Consumer Discretionary
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
25.2M
25.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RDI
NXPL
Price
$1.04
$0.60
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
469.8K
143.4K
Earning Date
11-14-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$211,292,000.00
$57,151,000.00
Revenue This Year
$1.06
N/A
Revenue Next Year
$10.97
N/A
P/E Ratio
N/A
N/A
Revenue Growth
7.11
N/A
52 Week Low
$1.02
$0.43
52 Week High
$1.87
$2.30

Technical Indicators

Market Signals
Indicator
RDI
NXPL
Relative Strength Index (RSI) 24.54 42.37
Support Level $1.08 $0.59
Resistance Level $1.27 $0.70
Average True Range (ATR) 0.07 0.06
MACD -0.01 0.00
Stochastic Oscillator 6.45 14.23

Price Performance

Historical Comparison
RDI
NXPL

About RDI Reading International Inc

Reading International Inc is a diversified company, engaged in the development, ownership, and operation of multiplex cinemas and retail and commercial real estate in the United States, Australia, and New Zealand. It operates through two segments: the Cinema segment includes Reading Cinemas, Angelika Film Center, Consolidated Theatres, and City Cinemas; the Real Estate segment includes real estate development and the rental or licensing of retail, commercial and live theater assets.

About NXPL NextPlat Corp

NextPlat Corp is an e-commerce and healthcare company. Its e-commerce venues form an effective network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operates in two segments: e-Commerce Operations involves acquiring and leasing an e-commerce platform; and Healthcare Operations provides TPA, data management, COVID-19 related diagnostics and vaccinations, prescription pharmaceuticals, and Others.

Share on Social Networks: